Natco Pharma, operating in the Pharmaceuticals sector and classified as a Smallcap on the BSE, currently has its share price at ₹746.85. The stock has experienced fluctuations today, with a low ...

Tata Equity P/E Fund - (G) 135.15 16,92,000 1.69 Tata Equity P/E Fund-(IDCW-Trigger-Opt B-10%) 135.15 16,92,000 1.69 Tata Equity P/E Fund - (IDCW-Trigger - Opt A - 5% ...

Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 14,823.13 Crore) operating in Pharmaceuticals sector. Natco Pharma Ltd. key Products/Revenue Segments ...

Natco Pharma Ltd. is a Public Limited Listed company incorporated on 19/09/1981 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is ...

Natco Pharma Ltd现在的股价报826.25 Natco Pharma Ltd的股票在哪间交易所挂牌交易？ Natco Pharma Ltd的股票在印度NSE挂牌交易。 Natco Pharma Ltd的股票代码是什么？ Natco Pharma Ltd的股票代码是“NATP。” Natco Pharma Ltd有分红吗？当前的股息收益率是多少？ Natco Pharma ...

Competition page helps you compare Natco Pharma Ltd. with its sector peers on key parameters.

Cash Taxes Paid 286.30 177.50 48.20 130.00 ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Mohammed Kabir is reshaping enterprise technology landscapes through large-scale digital transformations powered by artificial intelligence (AI). As a senior project manager at a Fortune 500 ...

The drug enhances the flow of blood through the lungs, allowing children with PAH to breathe and improve their ability to engage in physical activity.

Featured here, the Income Statement (earnings report) for Natco Pharma Ltd., showing the company's financial performance from operating and non operating activities such as revenue, expenses and ...

Featured here, the Cash Flow Statement for Natco Pharma Ltd., showing the changes in the company's cash and cash equivalents, broken down to operating, investing and financing activities over each of ...